Pharmaceutical industry – Page 7
-
OpinionRegulators must follow their heads, not their hearts
The 2019 US approval of antibiotic Recarbrio seems not to have met the normally expected standards
-
WebinarBuilding organisational consensus around the tools of digital chemistry
Learn how change agents at Johnson Matthey developed a coalition of support for data-driven science
-
BusinessDeadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
-
OpinionWill a court overturn abortion drug’s approval?
Tangle between regulation and politics makes uncomfortable viewing from industry
-
BusinessMerck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions
-
BusinessGhana and Nigeria approve Oxford malaria vaccine
Approval comes before final-stage clinical trials have been completed
-
BusinessJ&J proposes to pay nearly $9 billion to settle talc lawsuits
Company re-files for bankruptcy of a subsidiary in the hopes of resolving tens of thousands of claims its products caused cancer
-
OpinionMeeting the tigers of the lab
Practical teaching strikes a balance between removing hazards and learning to respect them
-
BusinessPfizer to buy cancer biotech Seagen for $43 billion
Antibody-drug conjugate specialist will fill Pfizer’s cancer pipeline
-
-
WebinarRobots in the lab – learn how automation can streamline your workflow
The future of lab automation is promising. This webinar session reveals the answers to the most important questions in chemistry related automation today
-
OpinionTurning negative results into positives
Publishing unsuccessful experiments is more important than ever as we try to train machines in chemistry
-
BusinessContaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
BusinessEncoding creativity in drug discovery
Machine learning can complement and reinforce human intuition and experience
-
OpinionThe psychology of our future with AI
It’s time to accept that digitalisation is changing laboratory work, and embrace the opportunity
-
BusinessMerck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
BusinessSecond Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects
-
OpinionSetting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
BusinessUK antibiotics supply chain stretched by surge in Strep A infections
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking